期刊文献+

人乳头瘤病毒感染与机体固有免疫反应 被引量:3

Human papillomavirus infection and host innate immune responses
原文传递
导出
摘要 人乳头瘤病毒可引起多种疾病,如寻常疣、扁平疣、尖锐湿疣、鲍恩样丘疹病、宫颈癌等。人乳头瘤病毒可以有效地逃逸固有免疫识别,其可能原因包括嗜上皮性、非溶解性复制、高免疫原性的衣壳蛋白在免疫活跃的复层鳞状上皮基底层呈低水平表达等。人乳头瘤病毒的致癌性以及所致疾病的临床高发病率受到人们的广泛关注。机体对抗人乳头瘤病毒的固有免疫已成为研究热点。概述多种皮肤免疫细胞,如角质形成细胞、树突细胞、朗格汉斯细胞、浆细胞样树突细胞、自然杀伤细胞和恒定型自然杀伤T细胞对人乳头瘤病毒固有免疫反应的相关研究。 Human papillomavirus (HPV) can cause a variety of diseases, such as verruca vulgaris, verruca plana, condyloma acuminatum, bowenoid papulosis, cervical cancer, and so on. Moreover, HPV can efficiently escape from the recognization by innate immune system, which may be attributed to epithelial tropism, non-lyric replication, and low expression of capsid protein with high immunogenieity in the basal lamina of immunoactive stratified squamous epithelium. The careinogenieity of HPV and high incidence of HPY-related diseases have received extensive attention. The innate immunity against HPV infection has become a research hotspot. In this review, the authors summarize multiple dermal immune cells involved in the innate immunity against HPV, including keratinocytes, dendritic cells, Langerhans cells, plasmaeytoid dendritic cells, natural killer cells and invariant natural killer T cells.
出处 《国际皮肤性病学杂志》 2015年第2期137-140,共4页 International Journal of Dermatology and Venereology
基金 2010年中国医师协会皮肤科医师分会一复旦张江光动力研究基金
关键词 人乳头瘤病毒 免疫学 逃逸反应 角蛋白细胞 树突细胞 郎格尔汉斯细胞 TOLL样受体 Human papillomavirus Immunology Escape reaction Keratinocytes Dendritic cells Langerhans cells Toll-like receptors
  • 相关文献

参考文献18

  • 1Stanley MA. Epithelial cell responses to infection with human papillomavirus[J]. Clin Microbiol Rev, 2012, 25(2): 215-522.
  • 2Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses [J]. Vaccine, 2012, 30 (Suppl 5): F55- 70.
  • 3Einstein MH, Schiller JT, Viseidi RP, et al. Clinician's guide to human papillomavirus immunology: knowns and unknowns[J]. Lancet Infect Dis, 2009, 9(6): 347-356.
  • 4Leong CM, Doorbar J, Nindl I, et aL Deregulation of E-cadherin by human papillomavirus is not confined to high-risk, cancer- causing types[J]. Br J Dermatol, 2010, 163(6): 1253-1263.
  • 5Conesa-Zamora P. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape[J]. Gynecol Oncol, 2013, 131 (2): 480-488.
  • 6Stanley M. Immune responses to human papillomavirus[J]. Yaecine, 2006, 24(Suppl 1): S16-22.
  • 7Amador-Molina A, Hern6ndez-Valencia JF, Lamoyi E, et al. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response [ J ]. Viruses, 2013, 5 ( 11 ) : 2624-2642.
  • 8Hibma MH. The immune response to papillomavirus during infection persistence and regression [J]. Open Virol J, 2012, 6: 241-248.
  • 9Black AP, Ardern-Jones MR, Kasprowicz V, et al. Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells [J].Eur J Imnmnol, 2007, 37(6): 1485-1493.
  • 10D' Costa Z J, Jolly C, Androphy E J, et al. Transcriptional repression of E-cadherin by human papillomavirus type 16 E6[J/ OL]. PLoS One, 2012, 7 ( 11 ): e48954[2012-11-26 ]. http://www. plosone.org/artiele/info% 3Adoi% 2F10.1371% 2Fjournal.pone. 0048954.

同被引文献17

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部